Kraig Biocraft Laboratories, Inc.
KBLB
$0.08
$0.000.00%
OTC PK
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 3.11% | -15.07% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 9.85% | -18.91% | |||
Operating Income | -9.85% | 18.91% | |||
Income Before Tax | -21.02% | 29.55% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -21.02% | 29.55% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -21.02% | 29.55% | |||
EBIT | -9.85% | 18.91% | |||
EBITDA | -9.93% | 19.03% | |||
EPS Basic | -16.67% | 25.00% | |||
Normalized Basic EPS | -25.00% | 20.00% | |||
EPS Diluted | -16.67% | 25.00% | |||
Normalized Diluted EPS | -25.00% | 20.00% | |||
Average Basic Shares Outstanding | 0.58% | 0.30% | |||
Average Diluted Shares Outstanding | 0.58% | 0.30% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |